Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008-2019

• Hoofdauteurs: Anna Maisa (Auteur), Christian Kollan (Auteur), Matthias an der Heiden (Auteur), Florian van Bömmel (Auteur), Markus Cornberg (Auteur), Stefan Mauss (Auteur), Heiner Wedemeyer (Auteur), Daniel Schmidt (Auteur), Sandra Dudareva (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Background: Germany is a low prevalence country for hepatitis B virus (HBV) infection with higher prevalence in vulnerable groups. The number of treated chronic hepatitis B (CHB) patients is unknown. We aimed to determine the number of CHB patients treated with nucleos(t)ide analogs (NUCs), the trea...